Join SightNation!
Become a citizen of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!
Communicate and Educate
Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling. Post questions to your peers.
Connect with Colleagues
Link up with professionals all over the nation. Share your ideas, thoughts and opinions. Collaborate on difficult cases and offer your insights.
Learn and Advance
Take CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on the latest eye care industry news.
Unite!
Engage with SightNation citizens to help create real reform on issues affecting the industry. Start or join groups about the issues most important to you.
Create an account and receive access to the personalized box below.
Hello New Member!
New Citizens
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Featured Blog
Featured Product
Featured Video
What’s Going On Across the Nation
SightNation News
Featured News
Essilor Steps Up Sun Protection Initiative With 10-Year Licensing Agreement for Safilo’s Polaroid Branded Ophthalmic Lenses - 05.21.2013
CHARENTON-LE-PONT, France and PADUA, Italy— Essilor (ESSI:PA) and Safilo (SFL:BrsaItaliana) have signed a 10-year licensing agreement for the design, manufacture and worldwide distribution by Essilor More »
Featured News
Researchers Use Tetris to Help Correct Amblyopia in Adults - 05.21.2013
Playing the popular 1980s video game Tetris could help treat adult amblyopia, according to a study in the April 22 issue of Current Biology. More »
Featured News
VM’s Top 50 U.S. Retailers Surpass $8 Billion in Estimated 2012 Sales - 05.20.2013
NEW YORK—The country’s 50 largest eyewear/eyecare retailers and optometric practices achieved another new high in combined optical sales in 2012, according to Vision Monday’s exclusive and signature r More »
Featured News
Results of Study Examining Unoprostone for Retinitis Pigmentosa Announced - 05.20.2013
At the recent Association for Research in Vision and Ophthalmology meeting, results of a study on R-Tech Ueno's unoprostone (development code UF-021) for retinitis pigmentosa were announced. More »
Essilor Launches New Crizal Consumer Ad Campaign - 05.17.2013
DALLAS— Essilor of America is launching a national advertising campaign that talks directly to consumers about the benefits of Crizal No-Glare lenses. More »
Arthritis Drug Dampens Dry Eye - 05.17.2013
Industry Gears Up for Optometry’s Meeting in June - 05.15.2013
Top Categories
- Eye Health (554)
- Industry News (640)
- Events and Meetings (188)
- Issues and Trends (236)
- Ophthalmic Surgery (22)
- People and Places (790)
- Practice Management (149)
- Products (350)
- Refractive Surgery / Vision Correction (34)
- Regulatory / Legislative News (94)
- Research (232)
- Technology (146)
- Therapeutics (77)
